Delivery Order SPE2DB22D2206-SPE2DB25FJS25
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of 4,564,825,651 units of the drug VARIZIG (varicella zoster immune globulin) in 1.2 ml vials. The contract has a ceiling value of $2,782.38 and a completion date of June 28, 2024. This contract is not set aside for any specific business type. AmerisourceBergen holds a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,392.70 firm fixed-price contract is for the supply of VARIZIG 125 UNIT/1.2 ML VIAL 1.2ML, with a period of performance through December 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,160.75 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 125 units of VARIZIG, a 1.2ml vial human immune globulin product. Performance will take place in Conshohocken, Pennsylvania over a one-month period concluding in mid-September. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor. No subcontractors or set aside designations were...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $12,636.12 to AmerisourceBergen Drug Corp for varicella virus vaccine on July 26, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price, non-set-aside delivery order is performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,159.03 on August 20, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive set-aside. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of VARIVAX vaccine with diluents. This $1,053.01 firm fixed price delivery order, which is not set-aside, has an ultimate completion date of September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,530.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on August 27, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- This is a $18,740.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the provision of VARIVAX VACCINE WITH DILUENTS, a vaccine product, with a period of performance through August 6, 2024. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts to supply a wide range of medical commodities, including specialty medications, generic drugs, and...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJS25Delivery Order
The Defense Logistics Agency awarded a $10,074.82 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of VARIZIG (Varicella Zoster Immune Globulin) 125 Unit/1.2 mL vials. This is a firm fixed price, competitively awarded contract with a completion date of September 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement and maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. The company has demonstrated capability to meet federal procurement requirements through open competition, as evidenced by its consistent receipt of non-set-aside competitively awarded contracts with the Defense Logistics Agency. This delivery order represents one of numerous transactions fulfilling the company's role as a primary supplier of medications, vaccines, and specialized medical commodities to support military healthcare systems, the Defense Health Agency, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 8/29/25 |